The down-regulation of IL1α and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization

Transplant International

Volumn 19, Issue 4, 2006, Pages 319-324

  Bladon, John ^a   Taylor, Peter C ^a  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Annexin V; Apoptosis; Cytokines; Extracorporeal photopheresis; Graft versus host disease; Monocytes

Indexed keywords

BREFELDIN A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE; STEROID; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; INTERLEUKIN 1;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY GRADIENT; DOWN REGULATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; LYMPHOCYTE CULTURE; MAGNETIC SEPARATION; MONOCYTE; PRIORITY JOURNAL; PUVA; SKIN LYMPHOMA; T CELL LYMPHOMA; CUTANEOUS T CELL LYMPHOMA; CYTOLOGY; IMMUNOLOGY; IN VITRO STUDY; METABOLISM;

ANNEXIN A5; APOPTOSIS; CYTOKINES; DOWN-REGULATION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; LYMPHOCYTES; LYMPHOMA, T-CELL, CUTANEOUS; MONOCYTES; PHOSPHATIDYLSERINES; PHOTOPHERESIS;

EID: 33645350371     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00278.x     Document Type: Article

References (34)

1. Edelson R Berger C Gasparro F et al. Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 1987 316 297.
2. Rook AH Suchin KR Kao DMF et al. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 1999 4 85.
3. Knobler R. Extracorporeal photochemotherapy - present and future. Vox Sang 2000 78 Suppl. 2 197.
4. Neuner P Charvat B Knobler R et al. Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UV-A. Photochem Photobiol 1994 59 182.
5. Klosner G Trautinger F Knobler R Neuner P. Treatment of peripheral blood mononuclear cells with 8-Methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response. J Invest Dermatol 2001 116 459.
6. Bladon J Taylor PC. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo. J Clin Apheresis 2002 17 177.
7. Bladon J Taylor PC. Early reduction in number of T cells producing proinflammatory cytokines, observed after extracorporeal photopheresis, is not linked to apoptosis induction. Transplant Proc 2003 35 1328.
8. Bladon J Taylor PC. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes. Photodermatol Photoimmunol Photomed 2005 21 293.
9. Bladon J Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T cell lymphoma and graft versus host disease patients. Br J Haematol 1999 107 707.
10. Vermes I Haanen C Steffens-Nakken H Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cell using fluorescein labelled Annexin V. J Immunol Methods 1995 184 39.
11. Fadok. VA Voelker DR Campbell PA Cohen JJ Bratton DL Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992 148 2207.
12. Wyllie AH Kerr JFR Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980 68 251.
13. Voll RE Herrmann M Roth EA Stach C Kalden JR Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997 390 350.
14. Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation Nat Rev Immunol 2004 4 223.
15. st edn.
16. Bladon J Taylor PC. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Dermatol 2002 146 59.
17. Suzuki T Kobayashi M Isatsu K et al. Mechanisms involved in apoptosis of human macrophages induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans in the presence of Cycloheximide. Infect Immun 2004 72 1856.
18. Li T Hu J Thomas JA Li L. Differential induction of apoptosis by LPS and taxol in monocytic cells. Mol Immunol 2005 42 1049.
19. Verhoven B Krahling S Schlegel A Williamson P. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ 1999 6 262.
20. Buchwald UK Geerdes-Fenge HF Vockler J Ziege S Lode H. Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone. Eur J Med Res 1999 4 85.
21. Wang P Wu P Siegel MI Egan RW Ballah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994 153 811.
22. de Waal Malefyt R Abrams J Bennett B Figdor CG de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991 174 1209.
23. Craciun LI Stordeur P Schandene L et al. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation 2002 74 995.
24. Di Renzo M Rubegni P Pasqui AL et al. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease. Brit J Dermatol 2005 153 59.
25. Tilg H van Montfrans G van den Ende A et al. Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 2002 50 191.
26. Reddy P Ferrara JLM. Immunobiology of acute graft-versus-host disease. Blood Rev 2003 17 187.
27. Liote F Boval-Boizard B Weill D Kuntz D Wautier JL. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression and cytokine release. Clin Exp Immunol 1996 106 13.
28. Podolsky DK. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2002 16 933.
29. Chiang KY Abhyankar S Bridges K Godder K Henslee-Downey JP. Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease. Transplantation 2002 73 665.
30. Maini R St Clair EW Breedveld F et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate a randomised phase III trials ATTRACT Study Group. Lancet 1999 354 1932.
31. Present DH Rutgeerts P Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999 340 1398
32. Couriel DR Hicks K Giralt S Champlin RE. Role of tumour necrosis factor- alpha inhibition with inflixiMAB in cancer therapy and haematopoietic stem cell transplantation. Curr Opin Oncol 2000 12 582.
33. Feldmann M Maini RN. Anti TNF alpha therapy of rheumatoid arthritis: what have we learned Annu Rev Immunol 2001 19 163.
34. Asadullah K Sterry W Volk HD. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 2003 55 241.